Topical ondansetron attenuates nociceptive and inflammatory effects of intradermal capsaicin in humans

European Journal of Pharmacology

Volumn 354, Issue 1, 1998, Pages

  Giordano, James ^a,b,c   Daleo, Charles ^a   Sacks, Steven M ^a  

^a HealthSouth Rehabilitation Hospital   (United States)

^b LAMAR UNIVERSITY   (United States)

^c Hengst Biotechnologies   (United States)

Author keywords

Human; Ondansetron; Pain

Indexed keywords

CAPSAICIN; ONDANSETRON; SEROTONIN 3 RECEPTOR;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; HYPERALGESIA; INFLAMMATION; NOCICEPTION; PAIN; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; CAPSAICIN; DERMATITIS, CONTACT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GELS; HUMANS; INJECTIONS, INTRADERMAL; NOCICEPTORS; ONDANSETRON; PAIN MEASUREMENT; PHOSPHATIDYLCHOLINES; SEROTONIN ANTAGONISTS;

EID: 0031664093     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00492-0     Document Type: Article

References (5)

1. 3 receptor antagonists reduce inflammatory pain in rats. Eur. J. Pharmacol. 170, 83.
2. Giordano, J., Sacks, S.M., 1997. Sub-anesthetic doses of bupivacaine or lidocaine increase peripheral ICS-205 930-induced analgesia against inflammatory pain in rats. Eur. J. Pharmacol. 334, 39.
3. Scott, J., Huskisson, E.C., 1979. Vertical or horizontal visual analogue scales. Ann. Rheumatol. Disease 38, 560.
4. Simone, D.A., Baumann, T.K., LaMotte, R.H., 1989. Dose-dependent pain and mechanical hyperalgeisa in humans after intradermal injection of capsaicin. Pain 38, 99.
5. Willimann, H., Walde, P., Luisi, P.L., Gazzaniga, A., Stroppolo, F., 1992. Lecithin organogel as matrix for transdermal transport of drugs. J. Pharm. Sci. 81, 871.